DCGI nod to drug developed using DRDO technology
New Delhi: A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday. The drug — ‘prussian blue’ insoluble formulations — was developed under the Technology Development Fund (TDF). The TDF was launched primarily for creating […] More